MENU
+Compare
CSTL
Stock ticker: NASDAQ
AS OF
Dec 23, 04:59 PM (EDT)
Price
$27.48
Change
-$0.05 (-0.18%)
Capitalization
608.02M

CSTL Castle Biosciences Forecast, Technical & Fundamental Analysis

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for CSTL with price predictions
Dec 20, 2024

CSTL in downward trend: 10-day moving average crossed below 50-day moving average on November 20, 2024

The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on November 20, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 11, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CSTL as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on December 11, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

CSTL moved below its 50-day moving average on December 09, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CSTL's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

CSTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 205 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.561) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.713) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CSTL is expected to report earnings to fall 87.50% to 0 cents per share on March 04

Castle Biosciences CSTL Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.58
Q1'24
Beat
by $0.23
Q4'23
Beat
by $0.48
The last earnings report on November 04 showed earnings per share of 7 cents, beating the estimate of 0 cents. With 87.65K shares outstanding, the current market capitalization sits at 608.02M.
A.I. Advisor
published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX25.490.21
+0.83%
Russell Inv US Small Cap Equity M
ZSCCX30.690.17
+0.56%
Zacks Small-Cap Core Inv
RYPCX6.920.03
+0.44%
Royce Small-Cap Fund Consult
FIONX13.61-0.02
-0.15%
Fidelity SAI International Index
BLYAX32.44-4.47
-12.11%
American Beacon Man Lg Cp Growth A

CSTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with VCYT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
+1.62%
VCYT - CSTL
39%
Loosely correlated
+4.66%
FLGT - CSTL
39%
Loosely correlated
-2.19%
MMSI - CSTL
38%
Loosely correlated
+2.03%
CTKB - CSTL
35%
Loosely correlated
+2.10%
MYGN - CSTL
35%
Loosely correlated
+1.44%
More